Editor's Note Preoperative use of GLP-1 receptor agonists was not significantly associated with an increased risk of aspiration pneumonia or acute respiratory failure after surgery, according to a March 4 report in MedPage Today. The article focuses on a retrospective cohort study of over 366,000 surgical patients found no meaningful…

Read More

Editor's Note Cataract surgery raises the risk of worsening diabetic retinopathy in adults with type 2 diabetes, according to a February 24 article in MedPage Today. The article focused on a a retrospective analysis published in the journal Ophthalmology. The study involved a large dataset from the TriNetX research network,…

Read More

Editor’s Note Preoperative use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) does not increase the risk of postoperative diabetic ketoacidosis (DKA) in patients undergoing emergency surgery, according to a study published February 19 in JAMA Surgery. These findings challenge the current FDA recommendation to withhold SGLT2i medications for at least three…

Read More

Editor's Note New infection control recommendations from the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) are purportedly the first comprehensive guidelines tailored specifically for regional anesthesia and interventional pain management procedures, such as cortisone injections and drug-delivery implants.   As detailed in the organization’s January 21…

Read More

Editor's Note Known for managing Type 2 diabetes and promoting weight loss, GLP-1 drugs like Ozempic and Wegovy may also reduce the risks of numerous other conditions, including Alzheimer’s, substance use disorders, and certain cancers, according to an article published in Fortune January 20. Led by the Veterans Affairs St.…

Read More

Editor's Note Despite a rise in discussions about bariatric surgery, a retrospective study spanning two decades revealed persistent racial and gender disparities in which patients undergo the procedure. MedPage Today reported the news January 16. The analysis, involving 122,487 patients, showed that only 9.1% with class II obesity or higher…

Read More

Editor's Note GLP-1 drugs may improve surgical outcomes without increasing risks for diabetic patients, according to a January 7 article in Medical Xpress. The article covers a study published in the Annals of Surgery finding that GLP-1 receptor agonists, such as semaglutide and tirzepatide, significantly reduced certain surgical complications in…

Read More

Editor's Note Bariatric surgery programs nationwide have reported a 20-25% decline in surgical volumes over the past year amid the rising use of glucagon-like peptide-1 (GLP-1) medications for obesity, OR Management News reported Dec 2. Although the connection between the decline and the popularity of the drugs cannot be definitively…

Read More

Editor's Note Access to GLP-1 medications is improving as manufacturers, insurers, and policymakers address high demand, costs, and coverage challenges, Becker’s Hospital Review reported December 13. As detailed in the article, Eli Lilly’s partnership with telehealth company Ro now allows patients to obtain Zepbound prescriptions online and receive shipments directly…

Read More

Editor's Note Demand for skin removal surgeries has risen sharply in the US, fueled by the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, CNN reported December 9. The trend reflects a growing need for procedures that address loose, sagging skin following significant weight loss, particularly as the…

Read More